Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Haruhito Sugiyama and Wataru Sugiura.
Haruhito Sugiyama
Connection Strength
0.465
Wataru Sugiura
  1. Efficacy and Safety of Inhaled Ciclesonide in Treating Patients With Asymptomatic or Mild COVID-19 in the RACCO Trial: Protocol for a Multicenter, Open-label, Randomized Controlled Trial. JMIR Res Protoc. 2020 Dec 31; 9(12):e23830.
    View in: PubMed
    Score: 0.230
  2. Seroprevalence of SARS-CoV-2 antibodies in a national hospital and affiliated facility after the second epidemic wave of Japan. J Infect. 2021 08; 83(2):237-279.
    View in: PubMed
    Score: 0.059
  3. Investigator initiated clinical trial of remdesivir for the treatment of COVID-19 in Japan. Glob Health Med. 2021 Apr 30; 3(2):62-66.
    View in: PubMed
    Score: 0.059
  4. Consistency of the results of rapid serological tests for SARS-CoV-2 among healthcare workers in a large national hospital in Tokyo, Japan. Glob Health Med. 2021 Apr 30; 3(2):90-94.
    View in: PubMed
    Score: 0.059
  5. Seroprevalence of antibodies against SARS-CoV-2 in a large national hospital and affiliated facility in Tokyo, Japan. J Infect. 2021 04; 82(4):e1-e3.
    View in: PubMed
    Score: 0.058
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.